(NASDAQ: IRTC) Irhythm Holdings's forecast annual revenue growth rate of 14.99% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Irhythm Holdings's revenue in 2026 is $787,851,000.On average, 17 Wall Street analysts forecast IRTC's revenue for 2026 to be $29,532,131,573, with the lowest IRTC revenue forecast at $28,276,130,340, and the highest IRTC revenue forecast at $30,507,159,219. On average, 17 Wall Street analysts forecast IRTC's revenue for 2027 to be $34,176,904,320, with the lowest IRTC revenue forecast at $32,320,506,892, and the highest IRTC revenue forecast at $35,918,611,944.
In 2028, IRTC is forecast to generate $39,533,476,824 in revenue, with the lowest revenue forecast at $36,970,209,000 and the highest revenue forecast at $42,162,469,464.